Aminoquinoxaline derivatives for treatment of neurodegenerative diseases
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
Sep 6, 2016
Grant Date -
Apr 24, 2014
app pub date -
Mar 30, 2012
filing date -
Mar 30, 2011
priority date (Note) -
In Force
status (Latency Note)
Importance
Abstract
The present invention relates to compounds of formula (I) below: for which: —X represents a hydrogen atom, a halogen atom, a group NO2 or NH2, —R0 represents H or —CH2—C≡CH, and —R1 and R2 each represent, independently of one another, a hydrogen atom; a saturated or unsaturated, linear or branched hydrocarbon-based chain comprising from 1 to 10 carbon atoms; or an optionally substituted aryl group, and also the pharmaceutically acceptable salts thereof, the stereoisomers thereof or mixtures of stereoisomers thereof in any proportion, in particular for use thereof as a medicament, in particular in the treatment or prevention of neurodegenerative diseases, and also the processes for the preparation thereof and the pharmaceutical compositions comprising same.
First Claim
Family
International Classification(s)
- [Classification Symbol]
- [Patents Count]
Cited Art Landscape
Patent Citation Ranking
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully